#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Granulomatosis with polyangiitis Osteosarcoma metastatic Extra-osseous Ewing's sarcoma recurrent Precursor T-lymphoblastic lymphoma/leukaemia recurrent Fragile X syndrome Plasma cell myeloma refractory Cold type haemolytic anaemia Arterial disorder Anaplastic thyroid cancer Malignant central nervous system neoplasm Neuroendocrine cell hyperplasia of infancy Hyperoxaluria Infection in an immunocompromised host Dent's disease Alpha-1 antitrypsin deficiency More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Basic Information Hereditary motor and sensory neuropathy – Treatment Short-bowel syndrome – Treatment Primary mediastinal large B-cell lymphoma – Basic Information Mantle cell lymphoma stage II – Trials in Disease Skin angiosarcoma Marginal zone lymphoma Pulmonary fibrosis – Life with Disease Uterine leiomyosarcoma – Life with Disease Chordoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cx-039776 Apitegromab Zibotentan Gtaexs617 Oditrasertib Annamycin Neridronate Sodium Desloratadine Tebentafusp Spiramycin Naproxen Sodium Ceftolozane Alendronate Sodium Monohydrate Maridebart Cafraglutide ZIMISLECEL Talquetamab Rtp-026 Sodium Maraviroc Redasemtide Sufentanil Citrate More therapies…

    Learn about Your Condition

    Tuberous sclerosis complex Post-traumatic headache Overweight Osteosarcoma Insulin resistance Rabies Glycogen storage disorder Type 1 diabetes mellitus Nervous system disorder Tardive dyskinesia Obliterative bronchiolitis Vertebrobasilar stroke Rectal cancer recurrent Anaemia Rhabdomyosarcoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Theagenio Cancer Hospital of Thessaloniki

Theagenio Cancer Hospital of Thessaloniki

Alexandrou Simeonidi str 2, Thessaloniki, 54639, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Warfarin Sodium
    • Acetylsalicylic Acid
    • Apixaban
    Austria Belgium Czechia Denmark Finland France +10

  • Evaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Amyloidosis
    Investigated Drugs:
    • GSK5764227
    • Bortezomib
    • Cyclophosphamide
    Greece Italy Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!